Serina Therapeutics (SER) Change in Receivables (2018 - 2023)
Serina Therapeutics (SER) posted Change in Receivables of -$10000.0 for Q4 2023, down 116.39% sequentially from $61000.0 in Q3 2023, and down 433.33% YoY from $3000.0 in Q4 2022.
Serina Therapeutics (SER) Change in Receivables (2018 - 2023) Analysis & Trends
Serina Therapeutics has reported Change in Receivables for 6 years, with the latest figure at -$10000.0 in Q4 2023.
- Quarterly Change in Receivables fell 433.33% year-over-year to -$10000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $53000.0 (up 352.38% YoY) and the FY2023 annual result came in at $53000.0, up 352.38% from the prior year.
- Change in Receivables eased to -$10000.0 in Q4 2023 per SER's latest filing, from $61000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $129000.0 in Q4 2019 and troughed at -$105000.0 in Q1 2021.
- A 5-year average of $8300.0 and a median of $1500.0 in 2019 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2020 and 2023: Change in Receivables tumbled 3650.0% in 2020, then jumped 654.55% in 2023.
- Over 5 years, Change in Receivables stood at $129000.0 in 2019, then slipped by 3.88% to $124000.0 in 2020, then plunged by 99.19% to $1000.0 in 2021, then surged by 200.0% to $3000.0 in 2022, then tumbled by 433.33% to -$10000.0 in 2023.
- According to Business Quant data, Change in Receivables over the past three periods registered -$10000.0, $61000.0, and -$1000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -10,000.00 |
| Dec 31, 2023 | -10,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | -11,000.00 |
| Sep 30, 2022 | -11,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Mar 31, 2022 | -25,000.00 |
| Mar 31, 2022 | -25,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Sep 30, 2021 | 13,000.00 |